FindTrial
Sign In

Clinical and imaging studies of denosumab on fracture healing of distal radius in postmenopausal women

Clinical and imaging studies of denosumab on fracture healing of distal radius in postmenopausal women

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066227
Enrollment
Unknown
Registered
2022-11-28
Start date
2022-11-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

experimental group:RANKL monoclonal antibodies + VitD3 + calcium carbonate
control group:VitD3 + calcium carbonate

Sponsors

Renji Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1,Age 50 - 75 years; 2,postmenopausal women; 3,fragility distal radius fractures; 4,patients undergoing open reduction and internal fixation.

Exclusion criteria

Exclusion criteria: 1,Patients with a history of distal radius fractures; 2,multiple injuries, open injuries, and high-violence injuries; 3,past or current anti-osteoporosis drugs; 4,long-term smoking, hormone use, or diabetes; 5,unable to cooperate with follow-up; 6,patients with conservative treatment.

Design outcomes

Primary

MeasureTime frame
Degree of Bone Healing;Wrist Function;—

Countries

China

Contacts

Public ContactXin Zhou

Renji Hospital, Shanghai Jiaotong University School of Medicine

83951034@qq.com13381706265

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026